Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Carcinoma, Hepatocellular 36Cholangiocarcinoma 12Carcinoma, Renal Cell 10Stomach Neoplasms 5Liver Neoplasms 5Neoplasms 4Endometrial Neoplasms 4Biliary Tract Neoplasms 4Uterine Cervical Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Vulvar Neoplasms 2Triple Negative Breast Neoplasms 2Thyroid Neoplasms 2Recurrence 2Ovarian Neoplasms 2Neoplasm Metastasis 2Liver Diseases 2Kidney Neoplasms 2Cirrhosis, Familial, with Pulmonary Hypertension 2Breast Neoplasms 2Advanced Solid Tumor 2von Hippel-Lindau Disease 1Urogenital Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thymoma 1Solid Tumor, Adult 1Solid Tumor 1Small Cell Lung Carcinoma 1Sarcoma 1Penile Neoplasms 1

Interventions

cabozantinib 7pembrolizumab 6Nivolumab 6Ipilimumab 5Axitinib 5Radiosurgery 3Blood Specimen Collection 3zimberelimab 2lenvatinib 2Ultrasonography 2Radiotherapy 2Biopsy 2tislelizumab 1polyethylene glycol 3350 1pazopanib 1palbociclib 1orellanine 1olaparib 1gallium Ga 68 dotatate 1fludarabine 1cyclopropapyrroloindole 1brodalumab 1belzutifan 1atezolizumab 1anlotinib 1adagrasib 1Watchful Waiting 1Vincristine 1Therapeutics 1Temozolomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Kidney Neoplasms × lenvatinib × Clear all
NCT06962787 2025-11-17

A Study of BL-B01D1+TKI±Pembrolizumab in Patients With Locally Advanced or Metastatic Renal Cancer

Sichuan Baili Pharmaceutical Co., Ltd.

Phase 2 Recruiting
260 enrolled
Genitourinary

Kidney Neoplasms

NCT06364631 2025-01-16

CARE1

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Recruiting
1,250 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚔